EKSO BIONICS HOLDINGS, INC. (NASDAQ:EKSO) filed a Form 8-K with the Securities and Exchange Commission on January 22, 2026, disclosing a material event.
EKSO BIONICS HOLDINGS, INC.'s stock currently trades at $7.91 with a market capitalization of $12.2M. The Healthcare company's stock moved following the disclosure.